Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 475 of 672 entries
View as:

Efficacy and Tolerability of Entospletinib in Combination With Systemic Corticosteroids as First-Line Therapy in Adults With Chronic Graft Versus Host Disease (cGVHD)

Phase: N/A Priority: Normal
NCT ID: NCT02701634 Org: User:
Start: 05/27/16 End: 03/06/18 Due: 03/06/19

Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed-Dose Combination ± Ribavirin for the Treatment of HCV (ION-3)

Phase: N/A Priority: Normal
NCT ID: NCT01851330 Org: User:
Start: 05/31/13 End: 03/31/14 Due: 03/31/15

Effect of Ranolazine on Myocardial Perfusion Assessed by Serial Quantitative Exercise SPECT Imaging

Phase: N/A Priority: Normal
NCT ID: NCT01221272 Org: User:
Start: 09/30/10 End: 09/30/12 Due: 09/30/13

Study to Evaluate the Safety and Efficacy of Selonsertib, Firsocostat, Cilofexor, and Combinations in Participants With Bridging Fibrosis or Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH)

Phase: N/A Priority: Normal
NCT ID: NCT03449446 Org: User:
Start: 03/21/18 End: 11/19/19 Due: 11/19/20

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Assess Safety and Efficacy of Ambrisentan in Subjects With Pulmonary Arterial Hypertension.

Phase: N/A Priority: Normal
NCT ID: NCT00423202 Org: User:
Start: 12/31/03 End: 10/31/05 Due: 10/31/06

Exploratory Study to Access the Metabolic Effects of Ranolazine in Subjects With Type 2 Diabetes Mellitus When Added to Ongoing Non-insulin Antidiabetic Therapy

Phase: N/A Priority: Normal
NCT ID: NCT01163721 Org: User:
Start: 06/30/10 End: 11/30/10 Due: 11/30/11

Presatovir in Lung Transplant (LT) Recipients With Respiratory Syncytial Virus (RSV) Infection

Phase: N/A Priority: Normal
NCT ID: NCT02534350 Org: User:
Start: 12/31/15 End: 09/27/17 Due: 09/27/18

Truvada Versus Truvada Plus Hepatitis B Immunoglobulin (HBIg) in Prevention of Chronic Hepatitis B Recurrence Post Liver Transplant

Phase: N/A Priority: Normal
NCT ID: NCT00507689 Org: User:
Start: 09/30/07 End: 05/31/11 Due: 05/31/12

Safety and Efficacy Study of Sofosbuvir Plus Ribavirin in Treatment-Naive Adults With Genotype 1 and 3 Chronic HCV Infection

Phase: N/A Priority: Normal
NCT ID: NCT01896193 Org: User:
Start: 06/30/13 End: 06/30/14 Due: 06/30/15

Pharmacokinetics of Entospletinib in Adults With Normal and Impaired Liver Function

Phase: N/A Priority: Normal
NCT ID: NCT02521376 Org: User:
Start: 11/16/15 End: 10/25/17 Due: 10/25/18

Surveillance Study of Respiratory Syncytial Virus Infection (RSV) in Subjects < 24 Months of Age

Phase: N/A Priority: Normal
NCT ID: NCT01754428 Org: User:
Start: 11/30/12 End: 05/31/13 Due: 05/31/14

Seladelpar in Subjects With Primary Biliary Cholangitis (PBC)

Phase: N/A Priority: Normal
NCT ID: NCT03301506 Org: User:
Start: 12/12/17 End: 11/30/28 Due: 11/30/29

A Phase II, Stratified, Randomized, Double-Blind, Multi-Center Study of the Safety and Efficacy of Adefovir Dipivoxil (ADF) at Two Dose Levels in Triple Combination Therapies With Protease Inhibitors (PI) and Nucleoside Reverse Transcriptase Inhibitors (RTI) for the Treatment of HIV-Infected Patient

Phase: N/A Priority: Normal
NCT ID: NCT00002184 Org: User:
Start: - End: - Due: -

Efficacy and Safety of Sofosbuvir/Velpatasvir ± Ribavirin for 12 Weeks in Adults With Chronic HCV Infection and Decompensated Cirrhosis

Phase: N/A Priority: Normal
NCT ID: NCT02996682 Org: User:
Start: 12/26/16 End: 05/08/18 Due: 05/08/19

Phase 1b Safety, Tolerability, and PK Study to Assess GS-5737 in Subjects With CF

Phase: N/A Priority: Normal
NCT ID: NCT01840735 Org: User:
Start: 05/31/13 End: 08/31/13 Due: 08/31/14

Safety and Efficacy of Bictegravir/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir + Emtricitabine/Tenofovir Disoproxil Fumarate in Treatment Naive, HIV-1 and Hepatitis B Co-Infected Adults

Phase: N/A Priority: Normal
NCT ID: NCT03547908 Org: User:
Start: 05/30/18 End: 03/07/24 Due: 03/07/25

Study to Evaluate the Safety, Tolerability, and Efficacy of Cilofexor in Adults With Primary Biliary Cholangitis Without Cirrhosis

Phase: N/A Priority: Normal
NCT ID: NCT02943447 Org: User:
Start: 12/01/16 End: 09/04/19 Due: 09/04/20

Tenofovir Disoproxil Fumarate/Emtricitabine/Efavirenz Versus Combivir/Efavirenz in Antiretroviral-Naive HIV-1 Infected Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00112047 Org: User:
Start: 07/31/03 End: 06/30/09 Due: 06/30/10

Study of Lenacapavir and Emtricitabine/Tenofovir Disoproxil Fumarate (F/TDF) for Prevention of HIV in People Who Inject Drugs (HPTN 103)

Phase: N/A Priority: Normal
NCT ID: NCT06101342 Org: User:
Start: 12/13/23 End: 12/31/28 Due: 12/31/29

Study Evaluating the Efficacy and Safety of Idelalisib in Combination With Bendamustine and Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL) (Tugela )

Phase: N/A Priority: Normal
NCT ID: NCT01569295 Org: User:
Start: 06/15/12 End: 06/10/19 Due: 06/10/20

A Clinical Study to Evaluate the Effects of Darusentan on Safety and Efficacy in Subjects With Resistant Systolic Hypertension Receiving Combination Therapy With Three or More Blood Pressure Lowering Drugs

Phase: N/A Priority: Normal
NCT ID: NCT00364026 Org: User:
Start: 06/30/04 End: 07/31/05 Due: 07/31/06

DORADO-AC - Optimized Doses of Darusentan as Compared to an Active Control in Resistant Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT00389779 Org: User:
Start: 09/30/06 End: 08/31/09 Due: 08/31/10

A Study to Evaluate the Safety, and Tolerability, and Efficacy of Seladelpar in Patients With PSC

Phase: N/A Priority: Normal
NCT ID: NCT04024813 Org: User:
Start: 11/12/19 End: 01/09/20 Due: 01/09/21

A Long Term Study of Ambrisentan in Pulmonary Arterial Hypertension Subjects Having Completed AMB-320 (NCT00423748) or AMB-321 (NCT00423202)

Phase: N/A Priority: Normal
NCT ID: NCT00578786 Org: User:
Start: 02/29/04 End: 03/31/10 Due: 03/31/11

Safety and Efficacy Study of Different Doses of 90Y-hPAM4 Combined With Gemcitabine in Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00603863 Org: User:
Start: 01/31/08 End: 12/31/13 Due: 12/31/14